Four to seven days after onset of fever, secondary dengue patients possessed a significantly higher percentage of CD19+,CD20−,CD27+,CD138− plasmablasts [12] (p = 0.0007) compared to control patients (Fig. 1A). The gene discussed is CD19; the disease is dengue disease.